Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-01-01 @ 11:40 AM
Study NCT ID:
NCT05129904
Status:
UNKNOWN
Last Update Posted:
2023-09-18
First Post:
2021-10-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)
Sponsor:
Nanfang Hospital, Southern Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NFEC-2021-259
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | UNKNOWN | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER_GOV | View |
| None | OTHER_GOV | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | UNKNOWN | View |
| None | UNKNOWN | View |
| None | OTHER | View |
| None | OTHER | View |
| None | UNKNOWN | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | UNKNOWN | View |
| None | UNKNOWN | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | UNKNOWN | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |